Moffitt Cancer Center Goes Pink with Hillsborough County Students

The program teaches the importance of healthy nutrition and exercise and the dangers of smoking.

Moffitt Researchers Identify Mechanism Controlling DNA Repair

βarrestin-1 regulates DNA repair by targeting 53BP1 for protein degradation

Moffitt Cancer Center to Advance Breast Cancer Immunotherapy Research with $8.3 Million Grant from Department of Defense

New study will evaluate a three-part combination treatment strategy in patients with brain-metastatic breast cancer

Moffitt Cancer Center and Ringling College to Bring Virtual Reality to Cancer Patients

Technology collaboration to improve patient experience and enhance health care training capabilities

AdventHealth, Moffitt Cancer Center join forces to improve cancer care for Floridians

The partnership will expand treatment and research in the Orlando and Tampa areas.

Out of Space, Moffitt Cancer Center Seeking Urgent State Support

New Hospital and Research Park Eyed in Partnership with Private Money

New USF President Joins Moffitt Cancer Center’s Institute Board

Currall was recently named president of the University of South Florida and will replace former USF President Judy Genshaft on Moffitt’s Institute...

Post-Traumatic Stress Disorder Linked to Increased Risk of Ovarian Cancer

New study suggests women who experience multiple PTSD symptoms have a much greater risk of developing the disease years later

Moffitt Cancer Center CEO Once Again Named a Physician Leader to Know

Moffitt Cancer Center Earns High Honor for Excellence in Nursing for the Second Time

Only 8% of U.S. hospitals achieve Magnet status and patients rely on this designation as the ultimate credential for high-quality nursing.

New Drug Combination Shows Promising Activity in Non-Small Cell Lung Cancer Patients

Moffitt Cancer Center study finds combination treatment of pembrolizumab and vorinostat is well tolerated, showing preliminary efficacy of therapy

Moffitt Researchers Develop Model to Personalize Radiation Treatment for Breast Cancer Patients

The genomically-adjusted radiation dose (GARD) can predict risk of local tumor recurrence and optimize radiation dose

Moffitt Researchers Complete Largest Genomic Analysis of Merkel Cell Carcinoma Patients

Two distinct populations of Merkel cell carcinoma identified; both exhibit similar responses to immunotherapy

Moffitt Researchers Discover Possible New Treatment Strategy for Lung Cancer

Combination therapy targeting KRAS mutation could provide benefit to nearly a third of lung cancer patients

Moffitt Researchers Identify Subtypes of Squamous Cell Lung Cancer

The subtypes have different genetic, chromosomal and protein alterations that could present therapeutic opportunities

News Releases